366 related articles for article (PubMed ID: 24962621)
21. Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein.
Wu J; Chalupny NJ; Manley TJ; Riddell SR; Cosman D; Spies T
J Immunol; 2003 Apr; 170(8):4196-200. PubMed ID: 12682252
[TBL] [Abstract][Full Text] [Related]
22. High-Throughput
Klussmeier A; Massalski C; Putke K; Schäfer G; Sauter J; Schefzyk D; Pruschke J; Hofmann J; Fürst D; Carapito R; Bahram S; Schmidt AH; Lange V
Front Immunol; 2020; 11():314. PubMed ID: 32153595
[TBL] [Abstract][Full Text] [Related]
23. Allele polymorphism and haplotype diversity of MICA/B in Tujia nationality of Zhangjiajie, Hunan Province, China.
Wang YJ; Zhang NJ; Chen E; Chen CJ; Bu YH; Yu P
Hum Immunol; 2016 May; 77(5):411-7. PubMed ID: 26972750
[TBL] [Abstract][Full Text] [Related]
24. The Donor Major Histocompatibility Complex Class I Chain-Related Molecule A Allele rs2596538 G Predicts Cytomegalovirus Viremia in Kidney Transplant Recipients.
Rohn H; Tomoya Michita R; Schwich E; Dolff S; Gäckler A; Trilling M; Le-Trilling VTK; Wilde B; Korth J; Heinemann FM; Horn PA; Kribben A; Witzke O; Rebmann V
Front Immunol; 2018; 9():917. PubMed ID: 29867932
[TBL] [Abstract][Full Text] [Related]
25. MICB polymorphisms and haplotypes with MICA and HLA alleles in Koreans.
Cha CH; Sohn YH; Oh HB; Ko SY; Cho MC; Kwon OJ
Tissue Antigens; 2011 Jul; 78(1):38-44. PubMed ID: 21554252
[TBL] [Abstract][Full Text] [Related]
26. NZ28-induced inhibition of HSF1, SP1 and NF-κB triggers the loss of the natural killer cell-activating ligands MICA/B on human tumor cells.
Schilling D; Kühnel A; Tetzlaff F; Konrad S; Multhoff G
Cancer Immunol Immunother; 2015 May; 64(5):599-608. PubMed ID: 25854583
[TBL] [Abstract][Full Text] [Related]
27. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.
Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M
FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909
[TBL] [Abstract][Full Text] [Related]
28. Membrane-bound versus soluble major histocompatibility complex Class I-related chain A and major histocompatibility complex Class I-related chain B differential expression: Mechanisms of tumor eradication versus evasion and current drug development strategies.
Suresh PK
J Cancer Res Ther; 2016; 12(4):1224-1233. PubMed ID: 28169232
[TBL] [Abstract][Full Text] [Related]
29. Sulforaphane induces ROS mediated induction of NKG2D ligands in human cancer cell lines and enhances susceptibility to NK cell mediated lysis.
Amin PJ; Shankar BS
Life Sci; 2015 Apr; 126():19-27. PubMed ID: 25721293
[TBL] [Abstract][Full Text] [Related]
30. The inhibitory effects of synthetic short peptides, mimicking MICA and targeting at NKG2D receptors, on function of NK cells.
Zhang B; Wei H; Zheng X; Zhang J; Sun R; Tian Z
Peptides; 2005 Mar; 26(3):405-12. PubMed ID: 15652646
[TBL] [Abstract][Full Text] [Related]
31. MICA, MICB and C1_4_1 polymorphism in Crohn's disease and ulcerative colitis.
Glas J; Martin K; Brünnler G; Kopp R; Folwaczny C; Weiss EH; Albert ED
Tissue Antigens; 2001 Oct; 58(4):243-9. PubMed ID: 11782275
[TBL] [Abstract][Full Text] [Related]
32. MICA and MICB allele assortment in Finland.
Koskela S; Tammi S; Clancy J; Lucas JAM; Turner TR; Hyvärinen K; Ritari J; Partanen J
HLA; 2023 Jul; 102(1):52-61. PubMed ID: 36919857
[TBL] [Abstract][Full Text] [Related]
33. Vigilin Regulates the Expression of the Stress-Induced Ligand MICB by Interacting with Its 5' Untranslated Region.
Berhani O; Nachmani D; Yamin R; Schmiedel D; Bar-On Y; Mandelboim O
J Immunol; 2017 May; 198(9):3662-3670. PubMed ID: 28356383
[TBL] [Abstract][Full Text] [Related]
34. [Expression of NKG2D ligands in multidrug-resistant nasopharyngeal carcinoma cell line CNE2/DDP and their effects on cytotoxicity of natural killer cells].
Mei JZ; Guo KY; Wei HM; Song CY
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):887-9. PubMed ID: 17584663
[TBL] [Abstract][Full Text] [Related]
35. Induction of MHC class I-related chain B (MICB) by 5-aza-2'-deoxycytidine.
Tang KF; He CX; Zeng GL; Wu J; Song GB; Shi YS; Zhang WG; Huang AL; Steinle A; Ren H
Biochem Biophys Res Commun; 2008 Jun; 370(4):578-83. PubMed ID: 18395517
[TBL] [Abstract][Full Text] [Related]
36. MICA-129 Dimorphism and Soluble MICA Are Associated With the Progression of Multiple Myeloma.
Zingoni A; Vulpis E; Cecere F; Amendola MG; Fuerst D; Saribekyan T; Achour A; Sandalova T; Nardone I; Peri A; Soriani A; Fionda C; Mariggiò E; Petrucci MT; Ricciardi MR; Mytilineos J; Cippitelli M; Cerboni C; Santoni A
Front Immunol; 2018; 9():926. PubMed ID: 29765374
[TBL] [Abstract][Full Text] [Related]
37. A typing system for the major histocompatibility complex class I chain related genes A and B using polymerase chain reaction with sequence-specific primers.
Rees MT; Downing J; Darke C
Genet Test; 2005; 9(2):93-110. PubMed ID: 15943549
[TBL] [Abstract][Full Text] [Related]
38. Variation in MICA and MICB genes and enhanced susceptibility to paucibacillary leprosy in South India.
Tosh K; Ravikumar M; Bell JT; Meisner S; Hill AV; Pitchappan R
Hum Mol Genet; 2006 Oct; 15(19):2880-7. PubMed ID: 16923796
[TBL] [Abstract][Full Text] [Related]
39. STAT3 inhibition by STA21 increases cell surface expression of MICB and the release of soluble MICB by gastric adenocarcinoma cells.
Garrido-Tapia M; Hernández CJ; Ascui G; Kramm K; Morales M; Ga Rate V; Zúñiga R; Bustamante M; Aguillón JC; Catala N D; Ribeiro CH; Molina MAC
Immunobiology; 2017 Nov; 222(11):1043-1051. PubMed ID: 28578917
[TBL] [Abstract][Full Text] [Related]
40. MUC1-C is a master regulator of MICA/B NKG2D ligand and exosome secretion in human cancer cells.
Morimoto Y; Yamashita N; Daimon T; Hirose H; Yamano S; Haratake N; Ishikawa S; Bhattacharya A; Fushimi A; Ahmad R; Takahashi H; Dashevsky O; Mitsiades C; Kufe D
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36754452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
